Doctor Yiyuan Huang

Doctor Yiyuan Huang

The Second Xiangya Hospital of Central South University, Changsha (China)

Member of:

Dr. Huang focused on studying the mechanism and treatment of HCM and Valvular Heart Disease since 2016. He and coleagues found a Novel drug targeting cardiomyocytes which directly inhibit myofilament contraction might prevent HCM disease phenotypic expression and progression, and developed a novel device to relieve the left ventricular outflow tract (LVOT) obstruction in patients with HCM.

Presentations

Trans-femoral transcatheter intramyocardial septal radiofrequency ablation: a novel therapeutic approach for obstructive hypertrophic cardiomyopathy

Event: ESC Congress 2024

Topic: Hypertrophic Cardiomyopathy

Session: Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock

Access

Association between silent cerebral embolism and cognitive alterations following transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valve patients

Event: ESC Congress 2024

Topic: Intervention

Session: Prosthetic heart valves: preventing thrombosis and stroke

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Yiyuan Huang

Biography

Contributor content

Trans-femoral transcatheter intramyocardial septal radiofrequency ablation: a novel therapeutic approach for obstructive hypertrophic cardiomyopathy

Association between silent cerebral embolism and cognitive alterations following transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valve patients

ESC 365 is supported by